Skip to main content

Endpoints in MDRO Clinical Trials

Jessica Howard-Anderson, MD, MSc, is an Assistant Professor of Medicine at Emory University School of Medicine and the Associate Hospital Epidemiologist at Emory University Hospital Midtown. She completed her medical school, residency and chief residency at University of California Los Angeles. Dr. Howard-Anderson completed fellowship training in infectious diseases at Emory University in 2021 and during … Read more

Molecular Characteristics of Vancomycin-Resistant Enterococci

Diana Panesso has a BSc, a master’s in microbiology and PhD in Biological Sciences all degrees obtained from Pontificia Universidad Javeriana in Bogota, Colombia. Dr. Panesso-Botero received a training in Molecular Microbiology at the University of Cambridge, UK, and the Institute Pasteur in Paris, France. Her PhD work was based on the characterization of a … Read more

From Bog to Bedside: The Story Behind the First Dedicated Phage Therapy Center in North America

Steffanie Strathdee, PhD, is Associate Dean of Global Health Sciences and Harold Simon Professor in the Department of Medicine at the University of California San Diego School of Medicine. She is also an Adjunct Professor at Johns Hopkins and Simon Fraser Universities. She co-directs UCSD’s new center for Innovative Phage Applications and Therapeutics (IPATH), Global … Read more

HIV Cure

Sarah Joseph, PhD, Assistant Professor, Microbiology and Immunology, and Guochun Jiang, PhD, Assistant Professor, Biochemistry and Biophysics

HIV Cure

Nancy Archin, PhD, Assistant Professor, Infectious Diseases

The One Health Approach to AMR

Sid Thakur, BVSc, MVSc, PhD, Professor of Molecular Epidemiology, Director of Global Health, NC State College of Veterinary Medicine.

HIV Persistence

Mary F. Kearney, PhD, HIV Dynamics and Replication Program, NIH Cancer Center